Events & Presentations
| Date | Event Details |
|---|---|
|
Nov 30, 2023 1:00 PM EST
|
Piper Sandler 35th Annual Healthcare Conference
|
|
Nov 29, 2023 4:30 PM EST
|
Arrowhead Pharmaceuticals Fiscal 2023 Year End Results
Prepared Remarks 270.1 KB
|
|
Nov 16, 2023 8:30 AM EST
|
Jefferies London Healthcare Conference
|
|
Nov 13, 2023 4:30 PM EST
|
Virtual Analyst and Investor Event on Plozasiran and Zodasiran
View Presentation 5.9 MB
|
|
Nov 11 - Nov 13, 2023
|
American Heart Association (AHA) Scientific Sessions 2023
AHA 2023 Plozasiran MUIR 642.6 KB
AHA 2023 Plozasiran SHASTA-2 1.1 MB
AHA 2023 Zodasiran ARCHES-2 483.1 KB
Title: ARO-APOC3, an Investigational RNAi Therapeutic, Silences APOC3 and Reduces Triglycerides to Near Normal Levels in Patients With Severe Hypertriglyceridemia: SHASTA-2 Study Results Title: ARO-APOC3, an Investigational RNAi Therapeutic, Silences APOC3 and Reduces Atherosclerosis-Associated Lipoproteins in Patients With Mixed Dyslipidemia: MUIR Study Results Title: ARO-ANG3, an Investigational RNAi Therapeutic, Silences the Expression of ANGPTL3 and Decreases Atherogenic Lipoproteins in Patients With Mixed Dyslipidemia: ARCHES-2 Study Results |
|
Nov 1, 2023
|
TIDES Europe 2023
View Presentation 3.7 MB
|
|
Oct 25, 2023
|
19th Annual Meeting of the Oligonucleotide Therapeutics Society (OTS)
View Presentation 1.6 MB
|
|
Oct 22, 2023
|
The 3rd International Research Conference on Neurodegenerative Diseases (IRCND 2023)
View Presentation 2.2 MB
Type: Oral Presentation
Title: Preclinical Profile of ARO-SOD1, an siRNA Therapy for SOD1-ALS |
|
Oct 18, 2023
|
Cracking the Code: The Dawn of Nucleic Acid Medicines
View Presentation 1.5 MB
Type: Poster Presentation
Title: Rank Order TRiMTM Activity Correlates with RISC Loading and Can Be Enhanced by cPrP Modification |
|
Oct 10, 2023
|
BMO Biopharma Spotlight Series: (R) Evolution of RNA Therapies
Type: Fireside Chat Presentation
|